Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Tree planting can be the most cost-effective way of removing carbon as long as careful choices are made about which type of trees to plant and where. Governments worldwide have committed to ...

Growing fruit trees in containers is an excellent way to enjoy fresh produce. Here in the UK, our unpredictable weather and limited outdoor space means that we often prioritise planting in pots.

Rotting logs turn out to be vital to forest biodiversity and recycling organic matter Katarina Zimmer, Knowable Magazine Though no one may be around to hear when a tree falls in the forest ...

As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a cash sweetener. Monday, Delaware’s state investment board approved a $ ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

HYDERABAD, India, Feb 26 (Reuters) - Drugmaker Merck (MRK.N), opens new tab, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the ...